Soy isoflavone supplements and prostate cancer: food patterns are not capsule proof
Observational soy findings and short supplement trials answer different questions and do not establish prostate cancer prevention.
Prostate supplement research, urinary symptoms, saw palmetto, nutrient claims, screening context, and questions for your clinician.
Observational soy findings and short supplement trials answer different questions and do not establish prostate cancer prevention.
Green tea as a beverage and concentrated extracts should not be treated as identical evidence or safety questions.
How to separate food research, biomarker findings, and unproven cancer prevention claims for lycopene.
Why a study of several ingredients together cannot establish what each ingredient does on its own.
A practical look at saw palmetto research, prostate symptom claims, product differences, and when urinary changes need medical attention.
Why a large prevention trial matters more than an antioxidant theory when evaluating prostate supplements.
A symptom record can clarify a medical discussion without turning a supplement purchase into a diagnosis.
A plain-language guide to the difference between supplement label wording, product quality, and proven clinical benefit.
Why a nutrient’s normal biological role cannot establish the benefit of high-dose zinc in a prostate supplement.